Association of the Gut Microbiome and Metabolome with Wheeze Frequency in Childhood Asthma

Overview

Journal J Allergy Clin Immunol

Specialty Allergy & Immunology

Date 2022 Feb 23

PMID 35196534

Authors

Kathleen Lee-Sarwar

Sandra Dedrick

Babak Momeni

Rachel S Kelly

Robert S Zeiger

George T OConnor

Megan T Sandel

Leonard B Bacharier

Avraham Beigelman

Nancy Laranjo

Diane R Gold

Jessica Lasky-Su

Augusto A Litonjua

Yang-Yu Liu

Scott T Weiss

Affiliations

Soon will be listed here.

Abstract

Background: While the microbiome has an established role in asthma development, less is known about its contribution to morbidity in children with asthma.

Objective: In this ancillary study of the Vitamin D Antenatal Asthma Reduction Trial (VDAART), we analyzed the gut microbiome and metabolome of wheeze frequency in children with asthma.

Methods: Bacterial 16S ribosomal RNA microbiome and untargeted metabolomic profiling were performed on fecal samples collected from 3-year-old children with parent-reported physician-diagnosed asthma. We analyzed wheeze frequency by calculating the proportion of quarterly questionnaires administered between ages 3 and 5 years in which parents reported the child had wheezed (wheeze proportion). Taxa and metabolites associated with wheeze were analyzed by identifying log fold changes with respect to wheeze frequency and correlation/linear regression analyses, respectively. Microbe-metabolite and microbe-microbe correlation networks were compared between subjects with high and low wheeze proportion.

Results: Specific taxa, including the genus Veillonella and histidine pathway metabolites, were enriched in subjects with high wheeze proportion. Among wheeze-associated taxa, Veillonella and Oscillospiraceae UCG-005, which was inversely associated with wheeze, were correlated with the greatest number of fecal metabolites. Microbial networks were similar between subjects with low versus high wheeze frequency.

Conclusion: Gut microbiome features are associated with wheeze frequency in children with asthma, suggesting an impact of the gut microbiome on morbidity in childhood asthma.

Citing Articles

Explore Alteration of Lung and Gut Microbiota in a Murine Model of OVA-Induced Asthma Treated by CpG Oligodeoxynucleotides.

Wang Q, Ji J, Xiao S, Wang J, Yan X, Fang L J Inflamm Res. 2025; 18():445-461.

PMID: 39816955 PMC: 11734504. DOI: 10.2147/JIR.S487916.

Genotype-microbiome-metabolome associations in early childhood and their link to BMI.

Aparicio A, Sun Z, Gold D, Lasky-Su J, Litonjua A, Weiss S mLife. 2025; 3(4):573-577.

PMID: 39744095 PMC: 11685832. DOI: 10.1002/mlf2.12153.

Distinct enterotypes and dysbiosis: unraveling gut microbiota in pulmonary and critical care medicine inpatients.

Li N, Tan G, Xie Z, Chen W, Yang Z, Wang Z Respir Res. 2024; 25(1):304.

PMID: 39127664 PMC: 11316369. DOI: 10.1186/s12931-024-02943-7.

Link between gut microbiota dysbiosis and childhood asthma: Insights from a systematic review.

Aslam R, Herrles L, Aoun R, Pioskowik A, Pietrzyk A J Allergy Clin Immunol Glob. 2024; 3(3):100289.

PMID: 39105129 PMC: 11298874. DOI: 10.1016/j.jacig.2024.100289.

Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma.

Nopsopon T, Chen Y, Chen Q, Wheelock C, Weiss S, McGeachie M ERJ Open Res. 2024; 10(4).

PMID: 39104961 PMC: 11298997. DOI: 10.1183/23120541.00931-2023.

References

Maceyka M, Spiegel S . Sphingolipid metabolites in inflammatory disease. Nature. 2014; 510(7503):58-67. PMC: 4320971. DOI: 10.1038/nature13475. View

Fitzpatrick A, Jackson D, Mauger D, Boehmer S, Phipatanakul W, Sheehan W . Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol. 2016; 138(6):1608-1618.e12. PMC: 5148729. DOI: 10.1016/j.jaci.2016.09.028. View

Satinsky B, Gifford S, Crump B, Moran M . Use of internal standards for quantitative metatranscriptome and metagenome analysis. Methods Enzymol. 2013; 531:237-50. DOI: 10.1016/B978-0-12-407863-5.00012-5. View

Li Z, Rava M, Bedard A, Dumas O, Garcia-Aymerich J, Leynaert B . Cured meat intake is associated with worsening asthma symptoms. Thorax. 2016; 72(3):206-212. DOI: 10.1136/thoraxjnl-2016-208375. View

Martin R, Szefler S, King T, Kraft M, Boushey H, Chinchilli V . The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol. 2007; 119(1):73-80. PMC: 2872157. DOI: 10.1016/j.jaci.2006.10.035. View

Holecek M . Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement. Nutrients. 2020; 12(3). PMC: 7146355. DOI: 10.3390/nu12030848. View

Trifilieff A, Fozard J . Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. J Pharmacol Exp Ther. 2012; 342(2):399-406. DOI: 10.1124/jpet.112.191585. View

Ono J, Worgall T, Worgall S . Airway reactivity and sphingolipids-implications for childhood asthma. Mol Cell Pediatr. 2015; 2(1):13. PMC: 4670439. DOI: 10.1186/s40348-015-0025-3. View

Vandeputte D, Kathagen G, Dhoe K, Vieira-Silva S, Valles-Colomer M, Sabino J . Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017; 551(7681):507-511. DOI: 10.1038/nature24460. View

10.

Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K . Population-level analysis of gut microbiome variation. Science. 2016; 352(6285):560-4. DOI: 10.1126/science.aad3503. View

11.

Bolyen E, Rideout J, Dillon M, Bokulich N, Abnet C, Al-Ghalith G . Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019; 37(8):852-857. PMC: 7015180. DOI: 10.1038/s41587-019-0209-9. View

12.

Barcik W, Pugin B, Westermann P, Rodriguez Perez N, Ferstl R, Wawrzyniak M . Histamine-secreting microbes are increased in the gut of adult asthma patients. J Allergy Clin Immunol. 2016; 138(5):1491-1494.e7. DOI: 10.1016/j.jaci.2016.05.049. View

13.

Price M, Oskeritzian C, Falanga Y, Harikumar K, Allegood J, Alvarez S . A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. J Allergy Clin Immunol. 2012; 131(2):501-11.e1. PMC: 3563730. DOI: 10.1016/j.jaci.2012.07.014. View

14.

Props R, Kerckhof F, Rubbens P, De Vrieze J, Hernandez Sanabria E, Waegeman W . Absolute quantification of microbial taxon abundances. ISME J. 2016; 11(2):584-587. PMC: 5270559. DOI: 10.1038/ismej.2016.117. View

15.

Chen H, Nwe P, Yang Y, Rosen C, Bielecka A, Kuchroo M . A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology. Cell. 2019; 177(5):1217-1231.e18. PMC: 6536006. DOI: 10.1016/j.cell.2019.03.036. View

16.

Ramadan A, Gaffin J, Israel E, Phipatanakul W . Asthma and Corticosteroid Responses in Childhood and Adult Asthma. Clin Chest Med. 2019; 40(1):163-177. PMC: 6355159. DOI: 10.1016/j.ccm.2018.10.010. View

17.

Marri P, Stern D, Wright A, Billheimer D, Martinez F . Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2012; 131(2):346-52.e1-3. PMC: 4403876. DOI: 10.1016/j.jaci.2012.11.013. View

18.

Nishiuma T, Nishimura Y, Okada T, Kuramoto E, Kotani Y, Jahangeer S . Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am J Physiol Lung Cell Mol Physiol. 2008; 294(6):L1085-93. DOI: 10.1152/ajplung.00445.2007. View

19.

Morton J, Marotz C, Washburne A, Silverman J, Zaramela L, Edlund A . Establishing microbial composition measurement standards with reference frames. Nat Commun. 2019; 10(1):2719. PMC: 6586903. DOI: 10.1038/s41467-019-10656-5. View

20.

Zahran H, Bailey C, Damon S, Garbe P, Breysse P . Vital Signs: Asthma in Children - United States, 2001-2016. MMWR Morb Mortal Wkly Rep. 2018; 67(5):149-155. PMC: 5812476. DOI: 10.15585/mmwr.mm6705e1. View